Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions.

× No keyword cloud information.

135 in total

1. Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.

Authors: Cm Hysek; Y Schmid; A Rickli; L D Simmler; M Donzelli; E Grouzmann; M E Liechti
Journal: Br J Pharmacol Date: 2012-08 Impact factor: 8.739

Review 2. Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options.

Authors: Guido Grassi
Journal: Curr Hypertens Rep Date: 2003-08 Impact factor: 5.369

3. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans.

Authors: B G Wallin; M Esler; P Dorward; G Eisenhofer; C Ferrier; R Westerman; G Jennings
Journal: J Physiol Date: 1992 Impact factor: 5.182

4. Sympathetic nerves and the endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries.

Authors: Hema Raina; Qingli Zhang; Albert Y Rhee; Thomas L Pallone; W Gil Wier
Journal: Am J Physiol Heart Circ Physiol Date: 2010-04-09 Impact factor: 4.733

5. Angiotensin II infusion model of hypertension: is there an important sympathetic component?

Authors: Thomas E Lohmeier
Journal: Hypertension Date: 2012-01-23 Impact factor: 10.190

6. Differences in sympathetic neuroeffector transmission to rat mesenteric arteries and veins as probed by in vitro continuous amperometry and video imaging.

Authors: Jinwoo Park; James J Galligan; Gregory D Fink; Greg M Swain
Journal: J Physiol Date: 2007-08-30 Impact factor: 5.182

Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions.

1. Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.

Review 2. Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options.

3. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans.

4. Sympathetic nerves and the endothelium influence the vasoconstrictor effect of low concentrations of ouabain in pressurized small arteries.

5. Angiotensin II infusion model of hypertension: is there an important sympathetic component?

6. Differences in sympathetic neuroeffector transmission to rat mesenteric arteries and veins as probed by in vitro continuous amperometry and video imaging.

Review 7. The sympathetic nervous system alterations in human hypertension.

Review 8. Physiological genomics of antidepressant targets: keeping the periphery in mind.

Review 9. Neural mechanisms and management of obesity-related hypertension.

Review 10. Thunderclap headache attributed to reversible cerebral vasoconstriction: view and review.